Welcome to LookChem.com Sign In|Join Free

CAS

  • or

900174-43-8

Post Buying Request

900174-43-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

900174-43-8 Usage

General Description

1-Bromo-2-(isopropanesulfonyl)benzene is a chemical compound with the molecular formula C10H13BrO2S. It is a highly reactive and potent electrophile, commonly used in organic synthesis as a sulfonating agent to introduce a sulfonyl group onto aromatic compounds. 1-BroMo-2-(isopropanesulfonyl)benzene has a bromine atom, and the sulfonyl group is attached to the benzene ring, making it a valuable intermediate in the production of pharmaceuticals, agrochemicals, and dyes. Additionally, it has been studied for its potential use in medicinal chemistry, particularly as a building block in the synthesis of bioactive molecules. However, due to its toxicity, flammability, and potential environmental hazards, it should be handled and used with caution in a controlled laboratory setting.

Check Digit Verification of cas no

The CAS Registry Mumber 900174-43-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,0,1,7 and 4 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 900174-43:
(8*9)+(7*0)+(6*0)+(5*1)+(4*7)+(3*4)+(2*4)+(1*3)=128
128 % 10 = 8
So 900174-43-8 is a valid CAS Registry Number.

900174-43-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-bromo-2-propan-2-ylsulfonylbenzene

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:900174-43-8 SDS

900174-43-8Relevant articles and documents

Ceritinib intermediate and method for preparing ceritinib

-

Paragraph 0110; 0111, (2019/05/28)

The invention relates to a ceritinib intermediate and a method for preparing ceritinib. A ceritinib intermediate compound is 4-isopropoxy-5-guanidyl-2-N-substituted piperidine-4-base toluene nitrate (VII). The method includes carrying out substation reaction on 2-nitro-4,5-dimethyl chlorobenzene and isopropyl alcohol in the presence of alkali to generate compounds III; carrying out condensation onthe compounds III and halogenated acetaldehyde di-acetal and carrying out reduction ring formation by ammonia-ammonium chloride-sodium borohydride to obtain compounds IV; carrying out amino protection to obtain compounds V; carrying out catalytic hydrogenation in solvents and carrying out nitro reduction to obtain amino so as to obtain compounds VI; carrying out reaction on the compounds VI and cyanamide to obtain compounds VII. The ceritinib can be prepared from the compounds VII by the aid of the method. The ceritinib intermediate and the method have the advantages of inexpensive and easilyavailable raw materials, simplicity and convenience in operation, high elementary reaction selectivity, low wastewater quantity and green environmental protection.

PHENYLGLYCINAMIDE DERIVATIVES USEFUL AS ANTICOAGULANTS

-

Page/Page column 83, (2008/06/13)

The present invention relates generally to phenylglycinamide derivatives that inhibit serine proteases. In particular it is directed to novel phenylglycinamide derivatives, and analogues thereof, which are useful as selective inhibitors of serine protease enzymes of the coagulation cascade; for example thrombin, factor VIIa, factor Xa, factor XIa, factor IXa, and/or plasma kallikrein. In particular, it relates to compounds that are factor VIIa inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 900174-43-8